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ABSTRACT
Background: Abdominal compartment syndrome (ACS) refers to organ dys-
function and ischemia resulting from intra-abdominal hypertension (IAH). Ischemia 
of the gut results in the triggering of a systemic inflammatory response by releasing 
cytokines which, in turn, causes capillary leakage leading to bowel edema, further 
increasing intra-abdominal pressure and resulting in a morbid cycle of ischemia and 
edema.
Objective: The aim of this study was to determine the effects of doxycycline 
on intestinal ischemia reperfusion (I/R) injury in a rat model of ACS.
Methods: Sprague-Dawley rats were divided into 5 equal groups. In groups 1 and 
2, saline (1 cc IP) was administered during induction of ACS and intestinal samples 
were removed at 1 and 24 hours, respectively, after decompression. In groups 3 and 4, 
doxycycline (10 mg/kg IP) was injected during induction of ACS and, similarly, in-
testinal samples were removed at 1 and 24 hours after decompression. In the control 
group (group 5), intestinal samples were collected without induction of ACS. Malon-
dialdehyde (MDA), interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, matrix 
metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinase-1 were studied 
and the apoptotic cells were enumerated histopathologically. Apoptosis and β-cell 
lymphoma 2 (βcl-2) expression were assessed immunohistochemically.
Results: Thirty-five rats were evenly divided into 5 groups of 7 rats each. MDA, 
IL-1β, IL-6, TNF-α, and MMP-2 levels were significantly higher in group 1 one hour 
after the reperfusion period compared with the control group (P < 0.001, P < 0.001, 
P < 0.05, P < 0.001, and P < 0.01, respectively). The same parameters were signifi-
cantly lower in group 3, in which doxycycline was administered, than in group 1 (P < 
0.001, P < 0.05, P < 0.05, P < 0.001, and P < 0.01, respectively). However, there 
¸
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was no significant difference between groups 2 and 4 in the 24th hour (all, P > 0.05). 
The mean (SD) number of apoptotic cells and the expression of βcl-2 was highest in 
group 2 at 24 hours after the reperfusion period (92.5 [11.4] and 35.9 [5.0], respec-
tively) and significantly greater than that in group 4 (P < 0.001 and P < 0.05, 
respectively).
Conclusion: Doxycycline was associated with protective effects against I/R in-
jury through decreasing apoptosis via attenuating the response of proinflammatory 
cytokines and inhibiting the activity of MMP-2 in this rat model. (Curr Ther Res Clin 
Exp. 2010;71:186–198) © 2010 Excerpta Medica Inc.
Key words: abdominal compartment syndrome, intestinal ischemia-reperfusion 
injury, doxycycline, apoptosis.
INTRODUCTION
The pressure within the abdominal cavity is normally atmospheric or subatmospheric 
and intra-abdominal hypertension (IAH) affects each organ system separately at differ-
ent levels of pressure.1 Abdominal compartment syndrome (ACS) refers to organ 
dysfunction and ischemia resulting from IAH. The gut is the organ most sensitive to 
IAH and Diebel at al2 found that mesenteric and intestinal mucosal flow was first reduced 
at 20 mm Hg before the renal, pulmonary, and cardiovascular systems were impaired.
Ischemia of the gut results in the triggering of a systemic inflammatory response 
by releasing cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-1, 
and IL-6, which, in turn, causes capillary leakage leading to bowel edema, further 
increasing intra-abdominal pressure (IAP), resulting in a morbid cycle of ischemia and 
edema.3
Increased IAP reduces blood flow to intra-abdominal organs and decompression 
may cause other serious problems including ischemia/reperfusion (I/R) injury.4–6 It is 
known that reperfusion of the ischemic tissue may promote the generation of various 
reactive oxygen metabolites (eg, superoxide radicals, hydrogen peroxide, and hydroxyl 
free radicals) which have deleterious effects on cell membranes by mediating lipid 
peroxidation.5,7 Besides their direct-damaging effects on tissues, free radicals may trig-
ger the accumulation of leukocytes in the tissue involved.4,5 It has been found that ac-
tivated neutrophils secrete enzymes (eg, myeloperoxidase, elastase, proteases) and liberate 
even more oxygen radicals further promoting inflammation and increasing levels of 
TNF-α, IL-1, IL-6, and malondialdehyde (MDA), an index of lipid peroxidation.4,5 All 
these processes lead to apoptosis, a crucial mechanism of I/R injury.8
Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade the extra-
cellular matrix and play important roles in inflammation, and neoplastic invasion and 
metastasis.9 MMPs are activated in I/R injury in the lung, heart, brain,9 kidney,10 and 
intestine.11,12 Ubiquitous tissue inhibitor of metalloproteinases (TIMPs) can interfere 
with MMP proteolytic activation and enzymatic activity.9 MMP expression via im-
mune cells is modulated by inflammatory mediators, such as TNF-α and IL-1β,13 and 
the precursors of these cytokines may be processed into biologically active forms by 
MMPs.14,15
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Doxycycline belongs to the family of tetracycline antibiotics and inhibits bacterial 
protein synthesis.16 Doxycycline induces the degradation of the pro-MMP zymogen 
or inhibits the transcription of MMP mRNAs16 and may also reduce apoptosis associ-
ated with β-cell lymphoma 2 (βcl-2) by inhibiting MMP-2 activity.17 Doxycycline has 
anti-inflammatory effects through lowering the expression of the genes encoding the 
proinflammatory cytokines, TNF-α and IL-1β.18 It may also up-regulate TIMP-1 ex-
pression.19 All of these features of doxycycline may have protective roles in I/R injury.
This study was designed to determine whether doxycycline has protective effects 
on the ACS, the mechanisms by which it facilitates these effects, and whether it has 
any possible relationship with apoptosis.
MATERIALS AND METHODS
Sprague-Dawley rats of either sex, weighing 225 to 250 g, were used in the present 
study. The rats were kept in individual cages and acclimated for ≥7 days before study 
initiation. All animals were kept in a temperature-controlled room (22±2°C) with a 
12-hour light-dark cycle with free access to water and standard laboratory chow. To 
induce ACS, the rats were anesthetized with ketamine (ketamine IM) and a catheter 
connected to a laparoscopic insufflator (Storz, Tuttlingen, Germany) was inserted in-
traperitoneally. IAP of 20 mm Hg was maintained by insufflating with carbon dioxide 
gas for 60 minutes.
Groups
Rats were divided evenly into 5 groups. In groups 1 and 2, saline (1 cc IP) was 
administered during induction of ACS and intestinal samples were removed 1 and 24 hours, 
respectively, after decompression. In groups 3 and 4, doxycycline (10 mg/kg IP) was 
injected during induction of ACS and, similarly, all tissue samples were collected 1 and 
24 hours after decompression. At the end of the reperfusion period, all animals were 
euthanized via decapitation prior to excision. Starting 2 cm distal to the ligament of 
Treitz, 5 cm of jejunum were excised and were homogenized (Ultra Turrax T18 basic 
homogenizer, IKA Works Inc., Wilmington, North Carolina) in 0.1 M phosphate 
buffer (pH = 7.4). The homogenates were centrifuged at 8000 rpm at 4°C for 10 min-
utes and the supernatants were removed to measure TNF-α, IL-1β, IL-6, MMP-2, 
and TIMP-1 levels using a commercially available ELISA kit (R&D Systems Inc., 
Minneapolis, Minnesota) and to analyze MDA levels via HPLC (Agilent 1100 Series, 
Agilent Technologies, Palo Alto, California) using commercial kits (Chromsystems 
Diagnostics, Munich, Germany). The results were expressed as nmol/mg protein. 
Protein concentrations of samples were spectrophotometrically estimated with com-
mercial kits purchased from Fluka (Buchs, Switzerland). In the control group (group 5), 
rats were anesthetized similarly but the inserted catheters were not inflated and intes-
tinal samples were collected 60 minutes after the induction of anesthesia.
Tissue specimens were fixed in 10% neutral buffered formalin for 18 to 24 hours 
according to routine procedures and embedded in paraffin. Slides were prepared from 
4- to 5-μm tissue sections according to standard surgical pathology procedures. The 
tissue sections were stained immunohistochemically with anti–βcl-2 and the apoptotic 
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cells were identified using a commercially available apoptosis detection kit (Apoptag 
Peroxidase In Situ Apoptosis Detection Kit, Chemicon, California). The counting of 
apoptotic and βcl-2+ cells on 6 different villi in each microscopic slide was performed 
by the same investigator blinded to animal group, under conventional light microscopy 
at a magnification of ×40.
All experimental protocols were approved by the Eskisehir Osmangazi University 
School of Medicine Animal Care and Use Committee.
Statistical Analysis
Statistical analyses were performed using SPSS 10.0 for Windows (SPSS, Inc., Chicago, 
Illinois). The results were analyzed by Kruskal-Wallis 1-way ANOVA with Tukey test for 
TNF-α, IL-1β, IL-6 and 1-way ANOVA with the Fisher least significant difference 
method for MDA, MMP-2, and TIMP-1. The histology data were analyzed by 1-way 
ANOVA with post hoc Scheffé tests. P < 0.05 was considered statistically significant.
RESULTS
TNF-α, IL-1β, and IL-6 levels were significantly higher in group 1 one hour after the 
reperfusion period following ischemia compared with the control group (TNF-α [P < 
0.001], IL-1β [P < 0.001], and IL-6 [P < 0.05]) (Table I); and were significantly 
lower in group 3, in which doxycycline was administered, than in group 1 (P < 0.001, 
P < 0.05, and P < 0.05, respectively). On the other hand, 24 hours after reperfusion, 
no significant difference in cytokine levels was observed between groups 2 and 4 
(Figure 1). The MDA levels were significantly higher 1 hour after the reperfusion 
period in group 1 compared with the control group (P < 0.001). MDA levels in group 
3, in which doxycycline was administered, were significantly lower than that in group 
1 (P < 0.001). The difference between the MDA levels at 1 hour after reperfusion was 
not observed at 24 hours (Figure 2).
MMP-2 levels were significantly higher in group 1 one hour after the reperfusion 
period compared with the control group (P < 0.01). In group 3, the MMP-2 level was 
significantly lower than that in group 1 (P < 0.01). At 24 hours after reperfusion, 
there was no significant difference between the groups administered saline (group 2) 
and doxycycline (group 4) (P > 0.05). However, the TIMP-1 levels were significantly 
higher in the groups administered doxycycline (groups 3 and 4) than the other groups 
(all, P < 0.05) (Figure 2).
Under the microscope, the immunohistochemically stained tissue samples revealed 
that there were only a few βcl-2+ cells in the control group, whereas a statistically 
increased number of βcl-2+ cells were noted in groups 1 and 3. The highest number 
of βcl-2+ cells was observed in group 2 (P < 0.01). In group 4, there remained only a 
small number of βcl-2+ cells and the difference between groups 2 and 4 was statisti-
cally significant (P < 0.05) (Figure 3A–3D, Table II). Similarly, the number of 
apoptotic cells observed in group 5 was significantly less than all of the other groups 
(groups 1, 3, 4 [P < 0.05]; and group 2 [P < 0.001]). The number of apoptotic cells was 
significantly higher in group 2 than in all of the other groups (P < 0.001) (Figure 4A– 
4D, Table III). 
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Figure 1.  The effect of doxycycline on intestinal tissue interleukin (IL)-1β, IL-6, and tumor 
necrosis factor (TNF)-α levels at 24 hours after ischemia/reperfusion injury due 
to abdominal compartment syndrome in a rat model. *P < 0.05 versus group 1; 
†P < 0.001 versus group 1.
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Figure 2.  The effect of doxycycline on intestinal tissue malondialdehyde (MDA), matrix 
metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinase-1 
(TIMP-1) levels at 1 hour after ischemia/reperfusion injury due to abdominal 
compartment syndrome in a rat model. *P < 0.001 versus group 1; †P < 0.01 
versus group 1; ‡P < 0.05 versus groups 1, 2, and 5.
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DISCUSSION
The protective effects of doxycycline and its derivative, minocycline, against I/R in-
jury and oxidative stress have been previously studied on different types of organs20–23
including intestine.24 However, in the present study, it was observed that doxycycline 
was associated with protective effects on I/R injuries of intestine induced by ACS. Sev-
eral possible mechanisms of action were found including attenuation of the response of 
proinflammatory cytokines and MMPs, decreased βcl-2 expression, and inhibition 
of apoptosis.
In the present study, IAP was maintained at 20 mm Hg for 1- and 24-hour reper-
fusion periods to maintain the I/R injury as Diebel et al manifested.2
Tissue MDA levels are assayed for products of lipid peroxidation as an indirect 
index of reactive oxygen metabolites and a biochemical marker of tissue I/R injury.5,7
A B
C D
Figure 3.  β-cell lymphoma 2 positive cells in rats in (A) group 1 (1 cc of saline adminis-
tered IP during induction of abdominal compartment syndrome [ACS] and intes-
tinal tissue removed 1 hour after decompression); (B) group 2 (1 cc of saline ad-
ministered IP during induction of ACS and intestinal tissue removed 24 hours after 
decompression); (C) group 3 (10 mg/kg of doxycycline administered IP during 
the induction of ACS and intestinal tissue removed 1 hour after decompression); 
(D) group 4 (10 mg/kg of doxycycline injected IP during induction of ACS and 
intestinal tissue removed 24 hours after decompression).
193
N.F. Yasar et al.¸
In the present study, the MDA levels were significantly higher after the 1-hour reper-
fusion period in group 1 compared with the control group, whereas it was lower in 
group 3, in which doxycycline was administered. In groups 2 and 4, the MDA levels 
were significantly lower compared with group 1, but there was no significant differ-
ence between these 2 groups. Previous studies6,25 also found increased intestine MDA 
levels in rodent models of ACS, in which IAP was maintained at 20 mm Hg for 1 hour; 
in the present study doxycycline appeared to block this tendency in group 3. How-
ever, we found that the MDA levels decreased spontaneously following 24 hours of 
reperfusion and there remained no difference between the groups administered saline 
and doxycycline.
Tissue I/R injury activates cascades which up-regulate cytokines (TNF-α, IL-1β, 
and IL-6), and has an important role in the initiation of systemic inflammatory reac-
tion. Spanos et al26 reported that the content of cytokines, including TNF-α, IL-1β, 
and IL-6, were increased significantly after 2 hours of ischemia and 2 hours of reper-
fusion in the intestine of male pigs (all, P < 0.05). Similarly, Di Paola et al27 reported 
that the tissue expression of TNF-α and IL-1β was increased after 45 minutes of is-
chemia and 1 hour of reperfusion in the intestine of rats (P < 0.01). In the present 
study, to better understand the possible effects of doxycycline on I/R injury, the 
TNF-α, IL-1β, and IL-6 levels were measured. The levels were all significantly higher 
in group 1 compared with the control group. However, the levels were significantly 
lower in group 3 than in group 1. It has been reported that doxycycline exhibits anti-
inflammatory effects in different tissues by inhibiting proinflammatory cytokines.28
Table II.  The number of β-cell lymphoma 2 positive cells in rats with 
intestinalischemia/reperfusion injury induced by abdominal 
compartment syndrome (ACS) (N = 35).
Group  
(n = 7 each) Mean (SD) Range
1*  25.23 (4.86) 18–33
2† 35.88 (5.02) 28–43
3‡ 24.25 (3.95) 20–29
4§ 14.88 (2.97) 9–20
5< 8.63 (2.73) 4–11
* Saline (1 cc IP) administered during induction of ACS; intestinal samples removed 
at 1 hour after reperfusion.
†  Saline (1 cc IP) administered during induction of ACS; intestinal samples removed 
at 24 hours after reperfusion.
‡  Doxycycline (1 cc IP) administered during induction of ACS; intestinal samples 
removed at 1 hour after reperfusion.
§  Doxycycline (1 cc IP) administered during induction of ACS; intestinal samples 
removed at 24 hours after reperfusion.
< The inserted catheters were not inflated and nothing was administered; intestinal 
samples were collected 60 minutes after induction of anesthesia.
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According to the experimental study of De Paiva et al,29 doxycycline suppressed in-
flammatory cytokines (IL-1β, TNF-α) in the corneal epithelium in dry eye in mice 
(P < 0.05 and P < 0.01, respectively). Kirkwood et al30 reported that doxycycline had 
potentially beneficial therapeutic effects in the prevention and treatment of metabolic 
bone diseases by modulating osteoblast and osteoclast activities through the inhibi-
tion of IL-1β–induced IL-6 secretion.
Doxycycline was associated with improved recovery from I/R injury through at-
tenuating the response of cytokines after a 1-hour reperfusion period; however, it did 
not appear to be associated with the spontaneous decrease observed after 24 hours.
MMPs are proteolytic enzymes that belong to a family of zinc-dependent enzymes 
that share a zinc-binding catalytic domain and are classified as collagenases (MMP-11, 
MMP-8, and MMP-13), gelatinases (MMP-2 and MMP-9), and stromelysins (MMP-3) 
on the basis of the substrate specificity of individual MMPs. TIMPs can interfere with 
A B
C D 
Figure 4.  Apoptotic cells in rats in (A) group 1 (1 cc of saline administered IP during induc-
tion of abdominal compartment syndrome [ACS] and intestinal tissue removed 
1 hour after decompression); (B) group 2 (1 cc of saline administered IP during 
induction of ACS and intestinal tissue removed 24 hours after decompression); 
(C) group 3 (10 mg/kg of doxycycline administered IP during induction of ACS and 
intestinal tissue removed 1 hour after decompression); (D) group 4 (10 mg/kg 
of doxycycline injected IP during induction of ACS and intestinal tissue removed 
24 hours after decompression).
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MMP proteolytic activation and enzymatic activity. MMPs are activated in I/R injury 
in the lung, heart, brain,9 kidneys,10 and intestine.11,12,31 They may also play a role in 
inflammation by affecting cytokines, such as TNF-α and IL-1β.6 Rosário et al11 found 
that infiltrating neutrophils in the postischemic intestine correlated positively with 
the densitometric measurement of MMP-9 monomers (r = 0.56; P = 0.02) and MMP-9 
dimers (r = 0.68; P = 0.004) in the zymogram and suggested that this gelatinase activi-
ty which was derived from MMP-9 was generated by infiltrating neutrophils. Similarly, 
Souza et al12 and Robinson et al31 suggested that there were significant increases in the 
postischemic intestinal levels of MMP-2, MMP-3, and MMP-9.
In the present study, we observed that the MMP-2 level was significantly higher in 
group 1 than in the control group 1 hour after the reperfusion period. Doxycycline 
was associated with significantly lower MMP-2 levels at the first hour compared with 
the control group and there remained no difference between group 3 and the control 
group. Twenty-four hours after reperfusion, there was no significant difference between 
groups 2 and 4.
TIMP-1 levels in groups 1, 2, and 5 were not significantly different. TIMP-1 was high-
est in group 4, but there was no significant difference compared with group 3. Even if 
TIMP-1 levels appeared to be numerically higher in the groups administered doxcycline, 
it is unlikely that there was a correlation between inhibition of MMPs by TIMP-1 and the 
recovery of the I/R injury observed in the first hour of reperfusion; whereas TIMP-1 ap-
peared to have inhibitory effects on MMP-2 primarily at 24 hours after the ischemia.
The protective effects of doxycycline were also studied immunohistochemically. For 
this purpose, the number of apoptotic cells and βcl-2 expression were evaluated in 
Table III.  The descriptives and the numbers of apoptotic cells in 
rats with intestinal ischemia/reperfusion injury induced by 
abdominal compartment syndrome (ACS) (N = 35).
Group  
(n = 7 each) Mean (SD) Range
1*  32.56 (7.86) 24–45
2† 92.50 (11.35) 83–118
3‡ 27.22 (5.72) 19–35
4§ 33.54 (6.98) 23–47
5< 15.90 (4.01) 10–21
* Saline (1 cc IP) administered during induction of ACS; intestinal samples removed 
at 1 hour after reperfusion.
†  Saline (1 cc IP) administered during induction of ACS; intestinal samples removed 
at 24 hours after reperfusion.
‡  Doxycycline (1 cc IP) administered during induction of ACS; intestinal samples 
removed at 1 hour after reperfusion.
§  Doxycycline (1 cc IP) administered during induction of ACS; intestinal samples 
removed at 24 hours after reperfusion.
< The inserted catheters were not inflated and nothing was administered; intestinal 
samples were collected 60 minutes after induction of anesthesia.
Current Therapeutic Research
196
ischemic intestinal tissue.21 As it is known, βcl-2 is a proliferative gene and sup-
presses apoptosis.21 It can be detected in normal and hyperplastic tissues, such as 
psoriasis and gingival hypertrophy, or malignant tissues.32 However, if a tissue is ex-
posed to I/R injury, the cells in that tissue have died to protect tissue from abnormal 
cell formation. It has been shown that βcl-2 overexpression protects enterocytes from 
I/R and subsequent injury by inhibiting apoptosis.33,34
In the present study, we found that the number of the βcl-2+ cells and apoptotic 
cells was highest in group 3. These results suggest that, to control increased apop-
tosis, the cells in the intestinal tissues express the βcl-2 gene for self-protection. On 
the other hand, the reduced apoptosis and βcl-2 expression in group 4, in which doxy-
cycline was administered, suggests that doxycycline may be involved in the protection 
of intestinal cells from I/R injury. Because the number of apoptotic cells was lower in 
intestinal tissue, it can be assumed that βcl-2 expression was diminished.
Smith and Gabler found that pretreatment with doxycycline (10 mg/kg; 2 hours 
prior to occlusion) significantly increased the survival time (up to 30%) (P < 0.05) 
in rats, in which the splanchnic artery was occluded for 1 hour and reperfusion was 
allowed for 2 hours. They proposed that this protective effect of doxycycline against 
I/R injury was due to suppression of leukocyte adherence to endothelial cells of the 
gastrointestinal tract and inhibition of the migration of adherent polymorphonu-
clear neutrophils.24 However, they could not explain how it was accomplished. It 
is our opinion that it produces functional protective effects by attenuating the 
response of proinflammatory interleukins in the acute phase following 1 hour of re-
perfusion while it reverses histopathologic changes by inhibiting the apoptotic 
mechanism at the 24th hour of reperfusion. We also believe that down-regulation of 
MMPs contributes to doxycycline’s protective effects against intestinal I/R injury.
CONCLUSIONS
Doxycycline, a tetracycline analogue, was associated with functional and histopatho-
logic protective effects against intestinal I/R injury caused by ACS in this rat model. 
These results need to be verified by larger animal studies and appropriate clinical 
studies.
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